News - BioPharm International

ADVERTISEMENT

News

GSK Accelerates Ebola Vaccine Development

October 24, 2014

GSK's investigational Ebola vaccine is in Phase I safety trials.

Unum Raises $12 million in Funding for ACTR-Based Cancer Treatment

October 24, 2014

Unum Therapeutics raised $12 million in Series A funding for its development of antibody-coupled T cell receptors (ACTRs) for the treatment of nonspecific tumor cells.

Despite AbbVie Snub, Shire Says it Will Double Sales by 2020

October 24, 2014

Shire announces it will expand its orphan drug portfolio and is ready for future M&A discussions.

Manufacturing Challenges of mAb Production: CHO or Plant Cells?

October 24, 2014

The latest Ebola epidemic sheds light on the delicate processes surrounding the manufacture of genetically modified live cells for biopharmaceutical production.

Novartis Reports Positive Results for Secukinumab in Ankylosing Spondylitis Trials

October 23, 2014

Secukinumab is the first IL-17A inhibitor to meet its primary endpoint in two Phase III trials for patients with ankylosing spondylitis.

Pall ForteBio Releases Bioprocessing Contamination Detection Kit

October 22, 2014

Pall ForteBio introduces a solution for quantifying residual host cell proteins in CHO cells.

FDA Panel Unanimously Backs Secukinumab for the Treatment of Psoriasis

October 22, 2014

An advisory committee recommends use of the first psoriasis therapy targeting IL-17A.

Roche to Expand and Improve its Basel Site

October 22, 2014

The renovation to Roche's historic office building in Basel, Switzerland will feature sustainable workplaces and a state-of-the-art research center.

EMA Works to Speed Up Ebola Treatment

October 20, 2014

The agency recommends that companies developing drugs to treat Ebola apply for orphan drug designation.

ADVERTISEMENT

ADVERTISEMENT

Click here